Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capivasertib (trade name: Truqap) is the world’s first approved AKT inhibitor ta···【more】
Release date：2026-01-13Recommended：135
Capivasertib is an investigational serine/threonine kinase (AKT) inhibitor.Is Ca···【more】
Release date：2026-01-13Recommended：121
Capivasertib is an oral kinase inhibitor that targets all three isoforms of the ···【more】
Release date：2026-01-13Recommended：145
Drugs used to treat cancer are usually highly potent and may cause numerous side···【more】
Release date：2026-01-13Recommended：158
Capivasertib (trade name: Truqap) is the world’s first approved AKT protein kina···【more】
Release date：2026-01-13Recommended：120
Capivasertib in combination with fulvestrant can be used as a second-line or thi···【more】
Release date：2026-01-13Recommended：84
Capivasertib in combination with Faslodex is indicated for the treatment of adul···【more】
Release date：2026-01-13Recommended：119
Capivasertib, in combination with Fulvestrant, is indicated for the treatment of···【more】
Release date：2026-01-13Recommended：108
Capivasertib belongs to a class of medications known as antineoplastic agents. I···【more】
Release date：2026-01-13Recommended：127
On November 17, 2023, AstraZeneca’s capivasertib in combination with Faslodex (f···【more】
Release date：2026-01-13Recommended：132
On June 12, 2023, the New Drug Application (NDA) for capivasertib in combination···【more】
Release date：2026-01-13Recommended：127
Capmatinib slows down or inhibits the spread of cancer cells by blocking a key p···【more】
Release date：2026-01-09Recommended：91
